Business Description
Shandong Lukang Pharmaceutical Co Ltd
ISIN : CNE000000P61
Share Class Description:
SHSE:600789: Class ATotal Employee Number:
6,469Compare
Compare
Traded in other countries / regions
600789.China Index Membership
SSE Composite Index IPO Date
1997-02-26Description
Shandong Lukang Pharmaceutical Co Ltd is a bio-pharmaceuticals company. It is engaged in manufacturing antibiotics, semi-synthetic antibiotics for human use, bio-pharmaceuticals for veterinary and agriculture use, intermediates, resins, starches, glucose and amino acids.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.8 | |||||
Equity-to-Asset | 0.52 | |||||
Debt-to-Equity | 0.51 | |||||
Debt-to-EBITDA | 12.94 | |||||
Interest Coverage | 4.5 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2 | |||||
Beneish M-Score | -3.07 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 0.3 | |||||
3-Year EBITDA Growth Rate | 3.7 | |||||
3-Year EPS without NRI Growth Rate | -3.5 | |||||
3-Year FCF Growth Rate | 182.7 | |||||
3-Year Book Growth Rate | 8.9 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 63.56 | |||||
9-Day RSI | 58.51 | |||||
14-Day RSI | 54.32 | |||||
3-1 Month Momentum % | -9.65 | |||||
6-1 Month Momentum % | -20.43 | |||||
12-1 Month Momentum % | -28.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.53 | |||||
Quick Ratio | 1.14 | |||||
Cash Ratio | 0.67 | |||||
Days Inventory | 104.96 | |||||
Days Sales Outstanding | 63.84 | |||||
Days Payable | 100.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.69 | |||||
Dividend Payout Ratio | 0.8 | |||||
3-Year Dividend Growth Rate | 30.8 | |||||
Forward Dividend Yield % | 0.69 | |||||
5-Year Yield-on-Cost % | 1.8 | |||||
3-Year Average Share Buyback Ratio | -5.6 | |||||
Shareholder Yield % | -0.57 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 22.26 | |||||
Operating Margin % | 4.95 | |||||
Net Margin % | 1.52 | |||||
EBITDA Margin % | 3.59 | |||||
FCF Margin % | 8.82 | |||||
OCF Margin % | 14.63 | |||||
ROE % | 1.96 | |||||
ROA % | 0.93 | |||||
ROIC % | 2.52 | |||||
3-Year ROIIC % | 26.47 | |||||
ROC (Joel Greenblatt) % | 4.43 | |||||
ROCE % | 3.34 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 92.13 | |||||
PE Ratio without NRI | 52.64 | |||||
Shiller PE Ratio | 35.1 | |||||
PEG Ratio | 6.27 | |||||
PS Ratio | 1.21 | |||||
PB Ratio | 1.49 | |||||
Price-to-Tangible-Book | 1.81 | |||||
Price-to-Free-Cash-Flow | 15.33 | |||||
Price-to-Operating-Cash-Flow | 8.96 | |||||
EV-to-EBIT | 40.67 | |||||
EV-to-EBITDA | 40.67 | |||||
EV-to-Revenue | 1.46 | |||||
EV-to-FCF | 16.52 | |||||
Price-to-GF-Value | 0.98 | |||||
Price-to-Projected-FCF | 1.82 | |||||
Price-to-DCF (Earnings Based) | 2.26 | |||||
Price-to-DCF (FCF Based) | 0.49 | |||||
Price-to-Median-PS-Value | 0.81 | |||||
Price-to-Peter-Lynch-Fair-Value | 3.58 | |||||
Price-to-Graham-Number | 2.06 | |||||
| Price-to-Net-Current-Asset-Value | 67 | |||||
Earnings Yield (Greenblatt) % | 2.46 | |||||
FCF Yield % | 6.54 | |||||
Forward Rate of Return (Yacktman) % | 16.2 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shandong Lukang Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 5,708.862 | ||
| EPS (TTM) (Â¥) | 0.08 | ||
| Beta | 0.8788 | ||
| 3-Year Sharpe Ratio | 0.07 | ||
| 3-Year Sortino Ratio | 0.09 | ||
| Volatility % | 18.58 | ||
| 14-Day RSI | 54.32 | ||
| 14-Day ATR (Â¥) | 0.269998 | ||
| 20-Day SMA (Â¥) | 7.0715 | ||
| 12-1 Month Momentum % | -28.09 | ||
| 52-Week Range (Â¥) | 6.48 - 11.3 | ||
| Shares Outstanding (Mil) | 1,045.19 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shandong Lukang Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shandong Lukang Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.050000 Cash Dividend | 2026-07-15 | 7.20 (+3.45%) | ||
| CNY 0.112000 Cash Dividend | 2025-06-27 | 10.05 (-0.50%) | ||
| CNY 0.020000 Cash Dividend | 2024-12-18 | 8.53 (-1.84%) | ||
| 1.3:1 Stock Split | 2019-06-19 | 6.48 (-1.40%) | ||
| 1.7:1 Stock Split | 2006-10-30 | 2.02 (+0.00%) | ||
| 1.1:1 Stock Split | 1998-05-29 | 3.73 (-1.31%) |
Show
Entries
Shandong Lukang Pharmaceutical Co Ltd Frequently Asked Questions
What is Shandong Lukang Pharmaceutical Co Ltd(SHSE:600789)'s stock price today?
The current price of SHSE:600789 is ¥7.37. The 52 week high of SHSE:600789 is ¥11.30 and 52 week low is ¥6.48.
When is next earnings date of Shandong Lukang Pharmaceutical Co Ltd(SHSE:600789)?
The next earnings date of Shandong Lukang Pharmaceutical Co Ltd(SHSE:600789) is .
Does Shandong Lukang Pharmaceutical Co Ltd(SHSE:600789) pay dividends? If so, how much?
The Dividend Yield %  of Shandong Lukang Pharmaceutical Co Ltd(SHSE:600789) is 0.69% (As of Today), Highest Dividend Payout Ratio of Shandong Lukang Pharmaceutical Co Ltd(SHSE:600789) was 4.5. The lowest was 0.15. And the median was 0.48. The  Forward Dividend Yield % of Shandong Lukang Pharmaceutical Co Ltd(SHSE:600789) is 0.69%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Shandong Lukang Pharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers